Published in Indian J Endocrinol Metab on December 01, 2012
Recombinant human leptin does not alter gut hormone levels after gastric bypass but may attenuate sweet cravings. Int J Endocrinol (2014) 0.77
Benefits of healthy adipose tissue in the treatment of diabetes. World J Diabetes (2014) 0.77
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med (2011) 11.01
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (2007) 7.01
PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest (2005) 3.34
Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med (2006) 3.24
Central insulin action in energy and glucose homeostasis. J Clin Invest (2006) 2.51
Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology (2009) 1.92
Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes (1999) 1.80
Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab (2005) 1.68
Hormone and glucose signalling in POMC and AgRP neurons. J Physiol (2009) 1.48
Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J (2002) 1.44
Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides (2007) 1.29
NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides (2004) 1.27
Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides (2009) 1.15
Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels. Diabetes (2002) 1.11
Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides (2006) 1.03
AAV-mediated leptin receptor installation improves energy balance and the reproductive status of obese female Koletsky rats. Peptides (2005) 1.01
Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology (2004) 0.99
Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin. Neurobiol Aging (2006) 0.99
Suppression of fat deposition for the life time with gene therapy. Peptides (2005) 0.97
Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides (2009) 0.96
Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy. Trends Pharmacol Sci (2005) 0.92
Neuroendocrine control of energy homeostasis: update on new insights. Prog Brain Res (2010) 0.90
Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery. Peptides (2005) 0.88
Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation. Peptides (2005) 0.87
Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract (2008) 0.87
Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches. Nutrition (2008) 0.85
Leptin deficiency: clinical implications and opportunities for therapeutic interventions. J Investig Med (2009) 0.85
Global life-long health benefits of repression of hypothalamic NPY system by central leptin gene therapy. Curr Top Med Chem (2007) 0.79
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology (2003) 2.14
Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer (2005) 1.65
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J (2004) 1.58
Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol (2007) 1.53
Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter (2012) 1.50
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol (2005) 1.41
Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev (2009) 1.38
Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology (2005) 1.32
Is obesity an inflammatory disease? Surgery (2003) 1.26
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology (2007) 1.25
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology (2007) 1.23
Cancer cachexia--pathophysiology and management. J Gastroenterol (2013) 1.20
Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.18
Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab (2008) 1.18
Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides (2009) 1.15
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care (2004) 1.15
Anorexia in space and possible etiologies: an overview. Nutrition (2002) 1.11
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry (2008) 1.09
Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol (2015) 1.08
Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides (2006) 1.03
Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol (2003) 1.03
Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg (2004) 1.02
Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry (2007) 1.01
The role of leptin in the control of insulin-glucose axis. Front Neurosci (2013) 1.00
Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology (2004) 0.99
Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res (2006) 0.98
Blunted metabolic response to fasting in obese mice. Endocrine (2007) 0.96
Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport (2010) 0.95
Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci (2006) 0.95
Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides (2010) 0.95
A role for pancreatic polypeptide in feeding and body weight regulation. Peptides (2007) 0.94
Roles of pancreatic polypeptide in regulation of food intake. Peptides (2002) 0.93
Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development. FASEB J (2007) 0.91
Opioid μ-receptors as new target for insulin resistance. Pharmacol Ther (2013) 0.90
Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia. J Gastroenterol Hepatol (2011) 0.90
Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric (2011) 0.89
Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PLoS One (2013) 0.89
Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol (2009) 0.89
Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition (2011) 0.89
Melanin-concentrating hormone enhances sucrose intake. Int J Mol Med (2005) 0.89
Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice. World J Gastroenterol (2008) 0.89
Leptin treatment ameliorates anxiety in ob/ob obese mice. J Diabetes Complications (2003) 0.88
Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice. PLoS One (2013) 0.87
Ob/ob mice as a model of delayed gastric emptying. J Diabetes Complications (2002) 0.87
Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus. J Neurosci Res (2010) 0.87
Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care (2005) 0.87
Control of food intake and muscle wasting in cachexia. Int J Biochem Cell Biol (2013) 0.86
Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa. Oncol Rep (2005) 0.86
NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition (2008) 0.86
Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophys Res Commun (2009) 0.86
The effect of mosapride citrate on constipation in patients with diabetes. Diabetes Res Clin Pract (2009) 0.86
Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry (2007) 0.85
Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun (2013) 0.85
Interleukin-1beta system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care (2004) 0.85
Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito. Crit Rev Oncog (2012) 0.84
Ghrelin and gastrointestinal movement. Methods Enzymol (2012) 0.84
Role of leucine in regulating food intake. Science (2006) 0.83
Dimorphic gene expression patterns of anorexigenic and orexigenic peptides in hypothalamus account male and female hyperphagia in Akita type 1 diabetic mice. Biochem Biophys Res Commun (2006) 0.82
Ghrelin and anorexia nervosa: a psychosomatic perspective. Nutrition (2011) 0.82
Ghrelin, des-acyl ghrelin and obestatin on the gastrointestinal motility. Peptides (2011) 0.82